Proteo Inc (PTEO) 0.1000 $PTEO Proteo, Inc. / Proteo

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Proteo Inc (PTEO) 0.1000 $PTEO

Proteo, Inc. / Proteo Biotech AG: Elafin Combined with Cyclosporine Promises to Overcome Limitations of Cyclosporine for Preventing Irreversible Damage to Transplanted Organs.
Business Wire - Thu Mar 12, 8:00AM CDT
Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG today announced the publication of new results from a group of researchers lead by Mark Nicolls at the Stanford School of Medicine which demonstrate that Elafin and cyclosporine A act synergistically to prevent the development of irreversible damage to transplanted lung tissue in an animal model.

Ischemia Reperfusion Injury - Pipeline Review, H1 2014
M2 - Mon Dec 15, 3:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/6pp4ft/ischemia) has announced the addition of the "Ischemia Reperfusion Injury - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Ischemia Reperfusion Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemia Reperfusion Injury and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Ischemia Reperfusion Injury - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Ischemia Reperfusion Injury pipeline depth and focus of Indication therapeutics - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Pharming Group N.V. - BioLineRx, Ltd. - Silence Therapeutics plc - Proteo, Inc. - Scynexis, Inc. - Prolong Pharmaceuticals - Trophos SA - Curatis Pharma GmbH - Alligator Bioscience AB - Opsona Therapeutics Ltd. - PledPharma AB - Zealand Pharma A/S - Omeros Corporation - Bolder Biotechnology, Inc. - Adienne S.r.l. - Genextra S.p.a. - KAEL-GemVax Co., Ltd. - Ischemix - APT Therapeutics, Inc. - Peptinnovate Limited For more information visit http://www.researchandmarkets.com/research/6pp4ft/ischemia
OMER: 24.58 (+0.44)

Proteo Biotech AG Expands Management Board
Business Wire - Fri Dec 05, 4:00AM CST
Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG today announced that the company strengthens its Management Board. The Supervisory Board of Proteo Biotech AG has appointed Dr. Juergen Paal as a new member of the company's Management Board, effective from Dec 1st, 2014. In this leadership role as Proteo Biotech AG's new Chief Operating Officer, he will be responsible for Proteo's clinical development program, product launch preparation, business development and partnering initiatives.

Proteo, Inc. / Proteo Biotech AG: Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery Completed
Business Wire - Fri Nov 21, 5:30AM CST
Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG today announced that the NHS Lothian's Edinburgh Heart Centre has completed final analysis of data from the investigator initiated Phase II clinical trial (EMPIRE study) with Proteo's drug candidate Elafin for prevention of myocardial injury after coronary artery bypass surgery (CABG). The EMPIRE study was designed as a randomized, double-blinded and placebo-controlled study on 87 patients to investigate the therapeutic potential of a single preoperative Elafin dose on postoperative myocardial injury. This was measured by troponin I plasma concentration which is released by damaged heart muscle cells and its plasma concentration correlates with overall damage of the heart muscle. It was assumed that this treatment would lower the troponin I release over 48 hours. Publication of the EMPIRE study results is planned in a peer reviewed journal.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Freight Rebound Sparks Strategic M&A Opportunities

Updated Category News Views 8

Is the Freight Recovery Here to Stay? Just when you thought trucking might have run out of gas, we're hitting a sharp turn back into growth town. For those of you dropping equity crumbs every which way but loose in the last few years, this freight lull has been brutal—like the hangover from hell. But Brown Gibbons Lang & Company’s fresh report now hints at a brighter...

Continue Reading
Tripo AI's EdenLive Sparks Major Leap in Real-Time Rendering

Updated Category News Views 3

Pushing Limits with EdenLive Tripo AI isn't just throwing a new gadget into the sea of tech; they're putting up a lighthouse. EdenLive, their blazing new real-time generative renderer, makes you re-think what on-the-fly animation can do. This ain't your average pixel pusher—it's a shot of adrenaline straight into the heart of interactive experiences. Let's chat Project...

Continue Reading
Harry Ritchie's Marks 70th Anniversary with Charity Event

Updated Category News Views 2

You don't sniff 70 years in retail without sewing some sturdy community threads. Harry Ritchie's, a stalwart in Eugene, Oregon's retail scene, just pulled a classic move: celebrating their seven-decade milestone by feeding folks instead of throwing a gala. In a world where local shops often vanish like ghosts, they're sticking with the founder's mantra from 1956: Be...

Continue Reading
PAG Secures $355M to Accelerate Aggressive Growth

Updated Category News Views 10

Platform Accounting's Bold Expansion Move When you hear about a $355 million strategic financing round, it paints a picture of company ambitions colored in big, bold strokes. Platform Accounting Group (PAG) has managed to secure such a hefty financial backing from Treville Capital Group, taking a serious shot at expanding its footprint and offerings. This is no small...

Continue Reading
Food Emulsifiers Market Set for Significant Growth

Updated Category News Views 5

Market Potential: Scratching the Surface Who would have thought that a tiny ingredient like food emulsifiers would hold such massive sway in the food industry? Well, here we are, peering into a future where the global food emulsifiers market could skyrocket to a whopping USD 5.07 billion by 2035. That's right, these unsung heroes of the food world are shaking things up,...

Continue Reading
iLAB Network Fuels Next-Gen Tech Startups with Innovation

Updated Category News Views 8

Igniting Innovation: 2150's New iLAB Network Here's the skinny on what's cookin' at the 2150 Center for Innovation, Commercialization & Growth. They've bagged another cohort for their iLAB network, and they’re laying the groundwork for the next wave of tech solutions that could shake things up across industries. Fresh Collaborations and Technological Foci Essentially,...

Continue Reading
Oberndorf, Bascom Snap Up San Jose Flats for $53M

Updated Category News Views 10

Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...

Continue Reading
Broadridge Gears Up for Fiscal Q1 Results Review

Updated Category News Views 6

Broadridge's Big Day: Mark Your Calendars Well, it looks like Broadridge Financial Solutions is setting the stage for its financial theatrics on November 3rd, 2026. If you're in the game of stock trading, chalk this up as a must-watch event. These folks at NYSE:BR are opening the books for their first quarter of fiscal year 2027, and you'd want to be tuned in when Tim...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 10

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Baidu Faces Class Action Over Misleading AI Revenue Claims

Updated Category News Views 6

Another Day, Another Lawsuit Nothing says 'start your week' quite like the sounds of courtroom battles echoing across the market landscape. Baidu, Inc. (NASDAQ: BIDU) finds itself in the legal crosshairs, courtesy of the DJS Law Group. They're being accused of some shady dealings, and the core of this drama is all about what they claimed versus the reality of their...

Continue Reading

Top 5 Most Recently Viewed Articles

IREN Limited Successfully Completes $440 Million Notes Offering

Updated Category News Views 254

IREN Limited Completes the Closing of $440 Million Offering IREN Limited (NASDAQ: IREN), an innovative leader in renewable energy-powered data centers, recently announced the successful closing of its convertible notes offering totaling $440 million. This significant move aims to enhance its financial standing and support its ambitious growth plans in the cryptocurrency...

Continue Reading
The Walt Disney Company's Future: Navigating Streaming Transition

Updated Category News Views 155

Disney's Transformation in the Streaming Era The Walt Disney Company is entering a significant phase as it prepares for the launch of ESPN's direct-to-consumer (DTC) streaming service. Analysts view this shift as both a risk and an opportunity, presenting potential gains alongside considerable challenges. The evolving sports rights landscape, with recently renegotiated...

Continue Reading
Empowering Michigan Residents with Energy Efficiency Initiatives

Updated Category News Views 46

The Partnership for Energy Efficiency in Michigan In a transformative collaboration, CLEAResult, a leading provider of energy efficiency services in North America, has partnered with Walker-Miller Energy Services, a prominent African American and woman-owned energy efficiency company, to enhance energy programs in Michigan. This initiative aims to leverage the Inflation...

Continue Reading
Australian Economy Prepares for Steady Interest Rates Ahead

Updated Category News Views 123

Australian Economy Prepares for Steady Interest Rates Ahead The Reserve Bank of Australia (RBA) is anticipated to maintain its current interest rates during the upcoming meeting. Attention has shifted to the timeline regarding when the central bank might initiate rate cuts. Currently, the benchmark cash rate stands at 4.35%, unchanged after the last increase late last...

Continue Reading
Exploring Exclusive Industries That Cater to the Wealthy Elite

Updated Category News Views 369

Industries Catering Exclusively to High Net Worth Individuals In recent discussions online, the spotlight has turned to various industries that exist solely to cater to the upper echelons of wealth. These sectors reflect lifestyles often beyond the comprehension of many, encapsulating preferences and needs that serve those with ample financial resources. 1. Family Offices...

Continue Reading